Sign in

CIK 0000894158

  • Non-accelerated filer
  • Smaller reporting company

Theriva Biologics, Inc.

Sign in to watch
Ticker
TOVX
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
133808303
Phone
+1 734-332-7800
Business address
9605 MEDICAL CENTER DRIVE, SUITE 270, ROCKVILLE, MD, 20850
Former names
Synthetic Biologics, Inc., ADEONA PHARMACEUTICALS, INC., PIPEX PHARMACEUTICALS, INC., SHEFFIELD PHARMACEUTICALS INC, SHEFFIELD MEDICAL TECHNOLOGIES INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 3 Insider Initial Statement of Ownership
  8. 4 Derivatives Options or other derivatives
  9. 4/A Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Returned to the company CEO & President returned 45,000 shares (to the company)
  12. 4 Grant or award CEO & President acquired 45,000 shares (grant or award)
  13. 4 Derivatives Options or other derivatives
  14. 3 Insider Initial Statement of Ownership
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Open-market buy Chief Executive Officer bought 7,136,380 shares at an average $0.89 ($44,428)
  18. 4 Exercise or conversion Director acquired 27,106 shares (option exercise)
  19. 4 Open-market buy Director bought 253,731 shares at $2.22 ($563,283)
  20. 4 Option exercise 10% owner acquired 618,855 shares (option exercise)

Page 6 of 8 · 156 filings